Fundraising Fox

Marianne Bjørdal

Investor

Partner at 3B Future Health Fund

France

Writes $100K – $5M checks · typically $1.5M

About

Marianne Bjørdal is a Partner at 3B Future Health Ventures, part of the Helsinn Group. She has a background in life science research and investment management, with focus on drug development and early-stage ventures.

Experience

  1. Helsinn Group -3B Future Health VenturesPartnercurrent2022 — present
  2. Helsinn Group -3B Future Health VenturesSenior Associate2019 — 2022
  3. Helsinn Group -3B Future Health VenturesInvestment Analyst2018 — 2019Monaco area
  4. Sibylla BiotechBoard Membercurrent2022 — present
  5. Epsilogen LtdBoard membercurrent2022 — present
  6. Kither BiotechBoard Observercurrent2022 — present
  7. Navion incBoard membercurrent2021 — present
  8. NeoPhore LtdBoard membercurrent2021 — present
  9. Gain TherapeuticsBoard Member2020 — 2021
  10. VirbacProject Monitor2018Nice Area, France
  11. CNRSResearcher2012 — 2017Nice Area, France
  12. CNRSPhD fellow2005 — 2011
  13. Norges forskningsrådPhD fellow2006 — 2011
  14. Sars International Centerresearch2000 — 2006
  15. Sars International Center for Marine Molecular BiologyResearch assistent2003 — 2005

Education

  1. Université Côte d'AzurDoctor of Philosophy (Ph.D.), Developmental and cellular biology2005 — 2009
  2. IAE Nice (Graduate School of Management)Master of Business Administration - MBA2017 — 2018
  3. University of Bergen (UiB)Cand. scient, Molecular biology1998 — 2003

Skills & more

Life Sciences5Biotechnology2venture capital1Science2Pharmaceutical IndustryResearch and Development (R&D)2Project Management2NeuroscienceBusiness1Project Planning1Genetics1Marketing Strategy
+4 moreFrenchEnglishNorwegianDrosophila

Languages English · French · Norwegian

From Marianne's professional profile.

Same school

Shared employers

Colleagues at 3B Future Health Fund

Network2

Investors connected to Marianne in public investor directories — a warm-intro map.